Protagenic Therapeutics, Inc.\new PTIX US Equity
$1.11
+0.20 (+21.98%)
USD · as of 2026-08-28 · marketstack
Returns are measured from 2018-07-25 — the price history has a 184-day gap before it.
Protagenic Therapeutics, Inc.\new (OTC: PTIX), an SEC filer in Pharmaceutical Preparations, closed at $1.11, +22.0%, on 2026-08-28, with a market cap of $2M and a return on equity of -236.1%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 13K |
| % of shares out | 0.7% |
| Days to cover | 1.1 |
| Δ vs 2026-07-31 | -0.8% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.